SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-22-250252
Filing Date
2022-09-23
Accepted
2022-09-23 17:04:42
Documents
9
Period of Report
2022-09-23

Document Format Files

Seq Description Document Type Size
1 PREM14A d370237dprem14a.htm PREM14A 715960
2 EX-FILING FEES d370237dexfilingfees.htm EX-FILING FEES 16144
3 GRAPHIC g370237g02a01.jpg GRAPHIC 28800
4 GRAPHIC g370237g02a02.jpg GRAPHIC 22395
5 GRAPHIC g370237g02a03.jpg GRAPHIC 20814
6 GRAPHIC g370237g02a04.jpg GRAPHIC 22887
7 GRAPHIC g370237g02a05.jpg GRAPHIC 22909
8 GRAPHIC g370237g04b06.jpg GRAPHIC 36699
9 GRAPHIC g370237g09a11.jpg GRAPHIC 39794
  Complete submission text file 0001193125-22-250252.txt   976472
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-39247 | Film No.: 221262928
SIC: 2834 Pharmaceutical Preparations